HCM
Howland Capital Management Portfolio holdings
AUM
$2.45B
1-Year Return
18.92%
This Quarter Return
+9.53%
1 Year Return
+18.92%
3 Year Return
+69.21%
5 Year Return
+110.29%
10 Year Return
+257.66%
AUM
$1.89B
AUM Growth
+$177M
(+10%)
Cap. Flow
+$27M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
38.93%
Holding
260
New
16
Increased
69
Reduced
114
Closed
11
Top Buys
| 1 |
Constellation Brands
STZ
|
$13.4M |
| 2 |
ANSS
Ansys
ANSS
|
$6.89M |
| 3 |
Veralto
VLTO
|
$4.35M |
| 4 |
S&P Global
SPGI
|
$3.76M |
| 5 |
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
|
$3.37M |
Top Sells
| 1 |
CarMax
KMX
|
$6.33M |
| 2 |
Danaher
DHR
|
$5.34M |
| 3 |
CVS Health
CVS
|
$4.6M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$4.23M |
| 5 |
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
|
$2.92M |
Sector Composition
| 1 | Technology | 18.11% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 9.52% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Communication Services | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bristol-Myers Squibb
BMY
$94.6B
| $1.26M | 0.07% |
24,565
-749
| -3% | -$38.4K |
|
127
iShares Core S&P Small-Cap ETF
IJR
$85B
| $1.21M | 0.06% |
11,186
-12
| -0.1% | -$1.3K |
|
128
Regeneron Pharmaceuticals
REGN
$59.7B
| $1.17M | 0.06% |
1,333
-8
| -0.6% | -$7.03K |
|
129
RTX Corp
RTX
$212B
| $1.08M | 0.06% |
12,837
-426
| -3% | -$35.8K |
|
130
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
$520M
| $1.02M | 0.05% |
39,880
+17,400
| +77% | +$444K |
|
131
CSX Corp
CSX
$60.6B
| $1M | 0.05% |
28,908
-300
| -1% | -$10.4K |
|
132
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
$1.91B
| $967K | 0.05% |
41,529
+27,890
| +204% | +$649K |
|
133
Becton Dickinson
BDX
$54.6B
| $947K | 0.05% |
3,883
-100
| -3% | -$24.4K |
|
134
Oracle
ORCL
$625B
| $940K | 0.05% |
8,920
+480
| +6% | +$50.6K |
|
135
3M
MMM
$81.5B
| $939K | 0.05% |
10,269
+978
| +11% | +$89.4K |
|
136
Tesla
TSLA
$1.08T
| $912K | 0.05% |
3,671
-162
| -4% | -$40.3K |
|
137
SPDR S&P MidCap 400 ETF Trust
MDY
$23.7B
| $905K | 0.05% |
1,777
-100
| -5% | -$50.9K |
|
138
Novo Nordisk
NVO
$250B
| $905K | 0.05% |
8,746
| – | – |
|
139
Brown-Forman Class A
BF.A
$13.4B
| $897K | 0.05% |
15,000
| – | – |
|
140
iShares Russell 2000 Value ETF
IWN
$11.8B
| $883K | 0.05% |
5,685
| – | – |
|
141
Nike
NKE
$111B
| $879K | 0.05% |
8,070
+982
| +14% | +$107K |
|
142
Technology Select Sector SPDR Fund
XLK
$83.5B
| $874K | 0.05% |
4,541
+1,345
| +42% | +$259K |
|
143
Coupang
CPNG
$52.3B
| $860K | 0.05% |
+53,140
| New | +$860K |
|
144
Intuit
INTU
$186B
| $853K | 0.05% |
1,365
| – | – |
|
145
Cisco
CSCO
$270B
| $852K | 0.05% |
16,861
+1,249
| +8% | +$63.1K |
|
146
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $830K | 0.04% |
14,965
-70
| -0.5% | -$3.88K |
|
147
General Mills
GIS
$26.5B
| $828K | 0.04% |
12,708
-272
| -2% | -$17.7K |
|
148
BP
BP
$88.8B
| $825K | 0.04% |
23,310
-2,542
| -10% | -$90K |
|
149
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $779K | 0.04% |
16,257
+3,566
| +28% | +$171K |
|
150
Alnylam Pharmaceuticals
ALNY
$59.5B
| $766K | 0.04% |
+4,000
| New | +$766K |
|